Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a recombinant human growth hormone presented as a solution for injection for subcutaneous use. It is indicated for treating growth hormone deficiency and related growth disorders in both children and adults. GNH USA supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Norditropin Flexpro, a recombinant human growth hormone, is used in conditions characterized by growth hormone deficiency or related growth disorders.

- Growth hormone deficiency in children: promotes linear growth and improves height velocity. - Growth hormone deficiency in adults: enhances body composition, bone density, and metabolic profile. - Turner syndrome: supports stature increase during puberty. - Chronic renal insufficiency: aids growth in pediatric patients with renal disease. - Prader‑Willi syndrome: helps improve growth and body composition.

Norditropin Flexpro may be associated with a range of adverse reactions.

Common Side Effects: - Injection site pain or erythema. - Headache. - Joint or muscle aches. - Peripheral edema. - Nausea. - Fatigue.

Serious or Rare Side Effects: - Intracranial hypertension. - Slipped capital femoral epiphysis. - Glucose intolerance or new‑onset diabetes. - Allergic reactions including anaphylaxis. - Increased intracranial pressure. - Tumor progression in patients with active malignancy.

When prescribing Norditropin Flexpro, clinicians should consider several safety measures.

- Monitor blood glucose: assess for hyperglycemia or diabetes. - Assess for intracranial hypertension: watch for headaches, visual changes. - Evaluate skeletal health: monitor for slipped epiphysis or scoliosis progression. - Adjust dose in renal impairment: consider reduced clearance. - Avoid use in active malignancy: growth hormone may stimulate tumor growth. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Norditropin Flexpro can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Glucocorticoids: may antagonize growth‑promoting effects. - Pegvisomant (GH receptor antagonist): blocks somatropin activity. - High‑dose insulin: risk of severe hypoglycemia.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: adjust dose as GH can affect thyroid metabolism. - Sex steroids (estrogen, testosterone): may enhance GH effects, requiring dose titration. - Diuretics: can exacerbate fluid retention. - Oral hypoglycemics: monitor glucose control closely.